Sunday, September 6, 2026
Home Authors Posts by Ogkologos

Ogkologos

4330 POSTS 0 COMMENTS

Efficacy of Taletrectinib in Patients with Advanced ROS1 Fusion-Positive NSCLC

Ogkologos -
0

EMA Recommends Extension of Indications for Glofitamab

Ogkologos -
0

Cancer Mortality Prediction for 2025 Continues to Show Favourable Trends In...

Ogkologos -
0

For AYAs with Advanced Cancer, Study Finds Serious Communication Gaps about...

Ogkologos -
0

Clinical Benefit of a Combination of Ipilimumab and Nivolumab in Treatment-Naïve...

Ogkologos -
0

Similar Efficacy Between Subcutaneous and Intravenous Pembrolizumab Given with Chemotherapy for...

Ogkologos -
0

FDA Approves Pembrolizumab for HER2 Positive Gastric or Gastro-oesophageal Junction Adenocarcinoma...

Ogkologos -
0

Expanding Research on Dormant Cancer Cells Aims to Prevent Metastasis

Ogkologos -
0

EMA Recommends Granting a Conditional Marketing Authorisation for Linvoseltamab

Ogkologos -
0

Adding Pembrolizumab to Docetaxel Does Not Significantly Improve Outcomes in Patients...

Ogkologos -
0
1...454647...433Page 46 of 433

MOST POPULAR

Load more

HOT NEWS

Follow us on Instagram @ogkologos

Το πρώτο ολοκληρωμένο portal για τον καρκίνο. Ενημερωθείτε για τον καρκίνο, καθώς και για τις τελευταίες εξελίξεις.
Contact us: info@ogkologos.com

POPULAR POSTS

POPULAR CATEGORY

Copyright © 2023 Ogkologos.com